BLOCKCHAIN

Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange

[ad_1] U.S. pharmaceutical company Verseon has become the latest medical organization to experiment in blockchain technology, it confirmed in a press release Tuesday, September 18.Verseon’s main product is its proprietary physics-based drug discovery platform. The company was established in 2002 and it now trades on the London Stock Exchange, boasting a market cap of £211 million ($277 million).Part of a growing trend among major pharmaceutical players to leverage blockchain’s data